Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2024-12-18Clinical Trial Update: CAR-macrophages for the Treatment of HER2 Overexpressing Solid Tumors [Phase 1]
This Phase 1 clinical trial update evaluates CAR-macrophages targeting HER2-overexpressing solid tumors, sponsored by Carisma Therapeutics. …
-
CLINICAL_TRIALS research · 2024-12-18Clinical Trial Update: Supplemental Screening for Women With Extremely Dense Breast Tissue: the DENSE-2 Trial [NA]
Update on the DENSE-2 trial evaluating supplemental screening for women with extremely dense breast tissue; the study is currently recruitin…
-
CLINICAL_TRIALS trial_result · 2024-12-18Clinical Trial Update: High Physical Activity During a Weight Loss Intervention for Breast Cancer Survivors and High Risk Women [NA]
This Clinical Trials update notes that the weight loss and high-physical-activity intervention study in breast cancer survivors and women at…
-
CLINICAL_TRIALS research · 2024-12-18Clinical Trial Update: Study of Pembrolizumab in Metastatic HER2-negative Breast Cancer Patients With APOBEC3B Mutation [Phase 2]
Phase 2 trial update for pembrolizumab in metastatic HER2-negative breast cancer patients with APOBEC3B mutation; the study status is active…
-
CLINICAL_TRIALS trial_result · 2024-12-18Clinical Trial Update: Effects of Exercise Oncology Intervention in Fitness Capacity and Body Composition in Breast Cancer Survivals [NA]
A completed clinical trial evaluating an exercise oncology program for breast cancer survivors to assess changes in fitness capacity and bod…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2024-12-18Clinical Trial Update: Preoperative Boost Associated With Neoadjuvant Chemotherapy in Luminal B Breast Cancer [NA]
A clinical trial is evaluating a preoperative radiotherapy boost in combination with neoadjuvant chemotherapy for Luminal B breast cancer, a…
-
CLINICAL_TRIALS trial_result · 2024-12-17Clinical Trial Update: AZD9833 China PK Study [Phase 1]
AstraZeneca's AZD9833 Phase 1 pharmacokinetic study in China for estrogen receptor–positive, HER2-negative metastatic breast cancer has comp…
-
CLINICAL_TRIALS trial_result · 2024-12-17Clinical Trial Update: Famitinib Plus SHR6390 and Endocrine Therapy in the Treatment of HR-positive, HER2-negative Advanced Breast Cancer [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating the combination of famitinib and SHR6390 with endocrine therapy for HR-positive, HER2-negative metasta…
-
CLINICAL_TRIALS research · 2024-12-17Clinical Trial Update: Axillary Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy in Patients With Initial cN1 Breast Cancer
This clinical trial update indicates recruitment for a study of axillary sentinel lymph node biopsy after neoadjuvant chemotherapy in patien…
-
CLINICAL_TRIALS trial_result · 2024-12-17Clinical Trial Update: Serratus Anterior Plane Block Versus Erector Spinae Plane Block With Dexmedetomidine Added to Bupivacaine for Ultrasound-Guided Pain Management After Mastectomy [NA]
A completed clinical trial comparing serratus anterior plane block and erector spinae plane block with dexmedetomidine added to bupivacaine …
-
CLINICAL_TRIALS trial_result · 2024-12-17Clinical Trial Update: Application of Single-Port Robot-Assisted Breast-Conserving Surgery Via Axillary Approach for Breast Cancer. [NA]
This clinical trial update describes a single-port robot-assisted breast-conserving surgery via the axillary approach for invasive breast ca…
-
CLINICAL_TRIALS research · 2024-12-17Clinical Trial Update: Precision Retrospective Integrative Study for Metastatic Lymph Nodes in Breast Cancer
A precision retrospective integrative study for metastatic lymph nodes in breast cancer is currently recruiting, funded by Centro di Riferim…
-
CLINICAL_TRIALS research · 2024-12-17Clinical Trial Update: Testing the Effectiveness of a Work Rehabilitation Intervention for Women with Breast Cancer [NA]
A clinical trial update describing a study to evaluate a work rehabilitation intervention for women with breast cancer. The trial is sponsor…
-
CLINICAL_TRIALS research · 2024-12-17Clinical Trial Update: Darsilide Combined With AI, Trastuzumab and Patuzumab in the Neoadjuvant Treatment of HR+/HER2+ Breast Cancer [Phase 2]
This clinical trial update indicates a Phase 2 neoadjuvant study of Darsilide combined with an aromatase inhibitor, trastuzumab, and Patuzum…
-
CLINICAL_TRIALS research · 2024-12-17Clinical Trial Update: Locally AblatiVe TherApy in OLigO-pRogressive SOlid TUmorS (VALOROUS) [NA]
VALOROUS is a clinical trial evaluating locally ablative therapy for oligoprogressive solid tumors and is currently recruiting, including br…
-
CLINICAL_TRIALS research · 2024-12-17Clinical Trial Update: Effects of Sensorimotor Training With Chemotherapy-Induced Peripheral Neuropathy in Breast Cancer Patients [NA]
A clinical trial is evaluating sensorimotor training to address chemotherapy-induced peripheral neuropathy in breast cancer patients and is …
-
CLINICAL_TRIALS other · 2024-12-17Clinical Trial Update: Study in Metastatic Breast Cancer Patients Receiving Eftilagimod Alpha or Placebo in Combination with Paclitaxel Chemotherapy [Phase 2, Phase 3]
Clinical trial update indicates a Phase 2/3 study of eftilagimod alpha in combination with paclitaxel for metastatic breast cancer is active…
-
FDA approval · 2024-12-16FDA Approved: ARIMIDEX — Supplemental Application (ANI Pharmaceuticals, Inc.)
The FDA approved a supplemental application for ARIMIDEX (anastrozole) filed by ANI Pharmaceuticals, Inc.
-
FDA approval · 2024-12-16FDA Approved: FEMARA — Supplemental Application (Novartis Pharmaceuticals Corporation)
FDA approved a supplemental application for FEMARA (letrozole) from Novartis Pharmaceuticals Corporation, updating the labeling or indicatio…
-
CLINICAL_TRIALS approval · 2024-12-16Clinical Trial Update: Named Patient Use Program to Provide Abemaciclib (LY2835219) for the Treatment of Metastatic Breast Cancer
Named patient use program for abemaciclib to treat metastatic breast cancer has been approved for marketing.
-
FDA approval · 2024-12-16FDA Approved: EXEMESTANE — Supplemental Application (Mylan Pharmaceuticals Inc.)
The FDA approved a supplemental application for Exemestane from Mylan Pharmaceuticals, finalizing approval of a generic Exemestane product. …
-
CLINICAL_TRIALS trial_result · 2024-12-16Clinical Trial Update: Metacognitive Strategy Training in Cancer-related Cognitive Impairment [NA]
A completed clinical trial evaluating metacognitive strategy training for cancer-related cognitive impairment in women with breast cancer. R…
-
CLINICAL_TRIALS research · 2024-12-16Clinical Trial Update: Anlotinib-based Combination Therapy in Patients with Hormone Receptor-positive（HR+） Metastatic Breast Cancer(MBC) .
A recruiting clinical trial evaluating anlotinib-based combination therapy for hormone receptor-positive metastatic breast cancer, sponsored…
-
CLINICAL_TRIALS research · 2024-12-16Clinical Trial Update: Tumoral Bone Strength Assessment by Numerical Simulation Using Quantitative CT : the MEKANOS Study
MEKANOS is a clinical trial evaluating tumoral bone strength using numerical simulation with quantitative CT in patients with bone metastase…
-
CLINICAL_TRIALS research · 2024-12-16Clinical Trial Update: Protein Needs Study [NA]
A recruiting clinical trial at the University of Alberta evaluating protein needs in colorectal cancer and breast cancer patients.